Any clinical benefit from the use of oncofoetal markers in the management of chemotherapy for patients with metastatic colorectal carcinomas?

Trillet-Lenoir, V; Chapuis, F; Touzet, S; Barbier, J Y; Freyer, G; Gaudin, J L; Lombard-Bohas, C; Valette, P J; Lledo, G; Gouttebel, M C; Boyer, J D; Chassignol, L; Hamon, H; Claudel-Bonvoisin, S; Leprince, E; Amoyal, P; Glehen, O; Darnand, P; Heilmann, M O; Bleuse, J P

Trillet-Lenoir, V; Chapuis, F; Touzet, S; Barbier, J Y; Freyer, G; Gaudin, J L; Lombard-Bohas, C; Valette, P J; Lledo, G; Gouttebel, M C; Boyer, J D; Chassignol, L; Hamon, H; Claudel-Bonvoisin, S; Leprince, E; Amoyal, P; Glehen, O; Darnand, P; Heilmann, M O; Bleuse, J P.

Affiliation

Trillet-Lenoir V; Medical Oncology Department, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Lyon, France. veronique.trillet-lenoir@chu-lyon.fr

Clin Oncol (R Coll Radiol) ; 16(3): 196-203, 2004 May.

Article in En | MEDLINE | ID: mdl-15191007

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Biomarkers, Tumor/analysis; CA-19-9 Antigen/analysis; Carcinoembryonic Antigen/analysis; Colorectal Neoplasms/drug therapy; Colorectal Neoplasms/pathology; Aged; Disease Progression; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Sensitivity and Specificity; Survival Analysis; Tomography, Spiral Computed; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Carcinoembryonic Antigen / Biomarkers, Tumor / CA-19-9 Antigen Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Oncol (R Coll Radiol) Journal subject: NEOPLASIAS Year: 2004 Type: Article Affiliation country: France

Search on Google

XML

PubMed Links